SC 13G 1 n.txt UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 MEDICALOGIC/MEDSCAPE, INC. ----------------------------------------------------------- (Name of Issuer) Common Stock, No Par Value ------------------------------ (Title of Class of Securities) 584642102 ---------------------------------- (CUSIP Number) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [x] Rule 13d-1(b) [_] Rule 13d-1(c) [_] Rule 13d-1(d) *The remainder of this cover page shall be filled out for a reporting person's initial filing of this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act, but shall be subject to all other provisions of the Act (however, see the Notes.) CUSIP NO. 584642102 ----------------------------------------------------------- 1. Names of Reporting Persons. DMI Capital Corp. I.R.S. Identification Nos. of above persons (entities only). 73-1649657 ----------------------------------------------------------- 2. Check the Appropriate Box if a Member of a Group a [_] b [_] ----------------------------------------------------------- 3. SEC Use Only ----------------------------------------------------------- 4. Citizenship or Place of Organization Iowa ----------------------------------------------------------- 5. Sole Voting Power Number of Shares 515,731 Beneficially ---------------------------------------- Owned by 6. Shared Voting Power Each Reporting 4,392,451 Person ---------------------------------------- With 7. Sole Dispositive Power 515,731 ---------------------------------------- 8. Shared Dispositive Power 4,392,451 ----------------------------------------------------------- 9. Aggregate Amount Beneficially Owned by Each Reporting Person 4,908,182 ----------------------------------------------------------- 10. Check if the Aggregate Amount in Row (9) Excludes Certain Shares [_] ----------------------------------------------------------- 11. Percent of Class Represented by Amount in Row (9) 9.47% ----------------------------------------------------------- 12. Type of Reporting Person IA ----------------------------------------------------------- Item 1(a). Name of Issuer: MedicaLogic/Medscape Inc. Item 1(b). Address of Issuer's Principal Executive Offices: 20540 NW Evergreen Parkway Hillsboro, Oregon 97124 Item 2(a). Name of Person Filing: DMI Capital Corp. Item 2(b). Address of Principal Business Office or, if None, Residence: 2420 Vine St #10 West Des Moines, IA 50265 Item 2(c). Citizenship: United States. Item 2(d). Title of Class of Securities: Common Stock Item 2(e). CUSIP Number: 584642102 Item 3. If This Statement is Filed Pursuant to Rule 13d-1(b), or 13d-2(b) or (c), Check Whether the Person Filing is a: (a) [_] Broker or dealer registered under Section 15 of the Exchange Act. (b) [_] Bank as defined in Section 3(a)(6) of the Exchange Act. (c) [_] Insurance company as defined in Section 3(a)(19) of the Exchange Act. (d) [_] Investment company registered under Section 8 of the Investment Company Act. (e) [x] An investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E); (f) [_] An employee benefit plan or endowment fund in accordance with Rule 13d-1(b)(1)(ii)(F); (g) [_] A parent holding company or control person in accordance with Rule 13d-1(b)(1)(ii)(G); (h) [_] A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act; (i) [_] A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act; (j) [_] Group, in accordance with Rule 13d- 1(b)(1)(ii)(J). Item 4. Ownership. (a) Amount Benefically Owned: DMI Capital Corp. in its capacity as investment adviser, may be deemed the beneficial owner of 4,908,182 shares of common stock of the Issuer. (b) Percent of Class: 9.47% (c) For information on voting and dispositive power with respect to the above listed shares, see Items 5 - 8 of Cover Page Item 5. Ownership of Five Percent or Less of a Class. If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following [ ]. Item 6. Ownership of More than Five Percent on Behalf of Another Person. Not applicable Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company. Not applicable. Item 8. Identification and Classification of Members of the Group. Not applicable. Item 9. Notice of Dissolution of Group. Not applicable. Item 10. Certification. By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. 2/14/2003 --------------------- Date /s/ Erich Riesenberg --------------------- Erich Riesenberg, DMI Capital Corp.